health π¬ Indian labs are cracking cancer care codes
Indian research institutes have launched two major studies tackling cancer's biggest hurdles. One study, led by Dr Shubhasis Haldar at SN Bose National Centre for Basic Sciences and Ashoka University, introduces an AI framework called ACSCeND to find cancer stem-like cells. This AI analyzes over 25,000 tumour samples to predict poor survival linked to pluripotent-like cells. Parallelly, researchers at IASST-Guwahati and IIT-Guwahati developed RK-251, a small molecule that only activates within malignant cells. This targeted approach promises to reduce the severe side effects of current chemotherapy treatments.